Literature DB >> 9681624

Carcinomas of the thyroid and breast associated with Pendred's syndrome: report of a case.

A Ozlük1, E Yildirim, S Oral, O Celen, U Berberoğlu.   

Abstract

We report herein the case of a 49-year-old woman with Pendred's syndrome who developed follicular carcinoma of the thyroid and invasive ductal carcinoma of the breast. To the best of our knowledge, this is the first case of different primary neoplasms developing in a patient with Pendred's syndrome.

Entities:  

Mesh：

Year:  1998        PMID： 9681624     DOI： 10.1007/s005950050207

Source DB:  PubMed          Journal:  Surg Today        ISSN： 0941-1291            Impact factor:   2.549


  5 in total

1.  Thyroid carcinoma in Pendred's syndrome.

Authors:  P Illum
Journal:  J Laryngol Otol       Date:  1978-05       Impact factor: 1.469

2.  Hyperfunctioning metastatic follicular thyroid carcinoma in Pendred's syndrome.

Authors:  R Abs; J Verhelst; E Schoofs; E De Somer
Journal:  Cancer       Date:  1991-04-15       Impact factor: 6.860

3.  Papillary carcinoma of the thyroid arising from dyshormonogenetic goiter.

Authors:  T Yashiro; K Ito; M Akiba; Y Kanaji; T Obara; Y Fujimoto; A Hirayama; H Nakajima
Journal:  Endocrinol Jpn       Date:  1987-12

4.  Congenital goiter and the development of metastatic follicular carcinoma with evidence for a leak of nonhormonal iodide: clinical, pathological, kinetic, and biochemical studies and a review of the literature.

Authors:  D S Cooper; L Axelrod; L J DeGroot; A L Vickery; F Maloof
Journal:  J Clin Endocrinol Metab       Date:  1981-02       Impact factor: 5.958

5.  Multiple primary breast and thyroid cancer.

Authors:  E Ron; R Curtis; D A Hoffman; J T Flannery
Journal:  Br J Cancer       Date:  1984-01       Impact factor: 7.640
  5 in total
  1 in total

1.  Targeted Next-Generation Sequencing Analysis of a Pendred Syndrome-Associated Thyroid Carcinoma.

Authors:  Guo-Xia Tong; Qing Chang; Diane Hamele-Bena; John Carew; Richard S Hoffman; Marina N Nikiforova; Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.